eslicarbazepine Tablets 200 mg, 400 mg, 600 mg, 800 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria
, Bulgaria
, Czech Republic
, Estonia
, France
, Germany
, Hungary
, Italy
, Latvia
, Lithuania
, Mexico
, Poland
, Romania
, Slovakia
, Sweden
, United Kingdom
, Bulgaria
, Czech Republic
, Estonia
, France
, Germany
, Hungary
, Italy
, Latvia
, Lithuania
, Mexico
, Poland
, Romania
, Slovakia
, Sweden
, United Kingdom
Comments
Indication: Epilepsy
Manufacturer #8070
A pharmaceutical manufacturer that develops, produces and markets both branded medicines and generics, with a focus on treatments for serious and chronic diseases. The company emphasises partnerships, licensing opportunities and specialist indication areas, supporting the global supply of pharmaceutical products via its research & development and manufacturing capabilities.
Manufacturer usually replies in 28 days
None